Alzheimer disease and risk of stroke A population-based cohort study

被引:103
作者
Chi, Nai-Fang [1 ,2 ,3 ]
Chien, Li-Nien [4 ]
Ku, Hsiao-Lun [6 ,7 ]
Hu, Chaur-Jong [1 ,2 ,3 ]
Chiou, Hung-Yi [3 ,5 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan
[3] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[4] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Hlth Care Adm, Taipei, Taiwan
[5] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan
[6] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan
[7] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan
关键词
INTRACEREBRAL HEMORRHAGE; BRAIN MICROBLEEDS; AMYLOID ANGIOPATHY; DIABETES-MELLITUS; APOLIPOPROTEIN-E; PREVALENCE; PATHOLOGY; DEMENTIA; SCORE;
D O I
10.1212/WNL.0b013e31828250af
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the risk of stroke in patients clinically diagnosed with Alzheimer disease (AD) compared with non-AD patients with similar vascular risk factors. Methods: Using data obtained from Taiwan's National Health Insurance Research Database, we evaluated the risk of ischemic stroke (IS) and intracerebral hemorrhage (ICH) in patients with AD (n = 980) who had no history of stroke, vascular dementia, or other cerebral degenerative diseases. Our evaluation period spanned from 2000 to 2010. We performed a 1: 5 case-control matched analysis, in which cases were matched to controls according to their estimated propensity scores, which were based on demographics and existing vascular risk factors. This approach reduced selection bias. Cox proportional hazards regression analysis was then used to estimate the risk of IS and ICH in AD, conditional for matched pairs. Results: Overall, patients with AD had a higher risk of IS and ICH than those without AD. The incidence of IS in AD cases and non-AD controls was 37.8 and 23.2 per 1,000 person-years, with an adjusted hazard ratio of 1.66 (95% confidence interval, 1.37-2.01, p < 0.001). The incidence of ICH in AD cases and non-AD controls was 5.2 and 3.0 per 1,000 person-years, with an adjusted hazard ratio of 1.70 (95% confidence interval, 1.03-2.79, p = 0.037). Conclusion: Clinical diagnosis of AD is associated with considerably increased risk of stroke development. Neurology (R) 2013;80:705-711
引用
收藏
页码:705 / 711
页数:7
相关论文
共 34 条
[1]   Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial [J].
不详 .
LANCET NEUROLOGY, 2008, 7 (01) :41-49
[2]  
[Anonymous], 2007, NEUROLOGY, V68, P1730
[3]  
[Anonymous], 2004, SAS SUGI
[4]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[5]   A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study [J].
Austin, Peter C. ;
Grootendorst, Paul ;
Anderson, Geoffrey M. .
STATISTICS IN MEDICINE, 2007, 26 (04) :734-753
[6]   Apolipoprotein E controls cerebrovascular integrity via cyclophilin A [J].
Bell, Robert D. ;
Winkler, Ethan A. ;
Singh, Itender ;
Sagare, Abhay P. ;
Deane, Rashid ;
Wu, Zhenhua ;
Holtzman, David M. ;
Betsholtz, Christer ;
Armulik, Annika ;
Sallstrom, Jan ;
Berk, Bradford C. ;
Zlokovic, Berislav V. .
NATURE, 2012, 485 (7399) :512-516
[7]  
Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub3, 10.1002/14651858.CD001190.pub2]
[8]   Vascular risk factors for Alzheimer's disease: An epidemiologic perspective [J].
Breteler, MMB .
NEUROBIOLOGY OF AGING, 2000, 21 (02) :153-160
[9]   Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies [J].
Cadavid, D ;
Mena, E ;
Koeller, K ;
Frommelt, RA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (09) :768-773
[10]   Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan [J].
Cheng, Ching-Lan ;
Kao, Yea-Huei Yang ;
Lin, Swu-Jane ;
Lee, Cheng-Han ;
Lai, Ming Liang .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (03) :236-242